To analyze clinical characteristics and treatment outcomes of colorectal cancer patients with brain metastases (BM) at two high-volume cancer centers, highlighting the significance of these outcomes.
Key Findings:
279 patients with CRC and BM were included, with 48.4% treated in Wuerzburg and 51.6% in Frankfurt, and specific treatment outcomes should be detailed.
Mean age at CRC diagnosis was 62.1 years; mean age at BM diagnosis was 65.1 years.
61.6% of patients were male; 11.1% had synchronous BM.
Rectal cancer was the primary site in 48.4% of cases; systemic metastases were common.
Surgical resection of BM was performed in 36.2% of patients.
Interpretation:
The study highlights the clinical characteristics and treatment patterns of CRC patients with BM, indicating a need for improved therapeutic strategies due to the poor prognosis associated with BM and the implications for future research.
Limitations:
Retrospective design may introduce selection bias, potentially affecting the reliability of the findings.
Data on KRAS mutation status in BM was not available.
Limited generalizability due to single-center data.
Conclusion:
The findings underscore the complexity of managing CRC patients with BM and the necessity for further research to optimize treatment approaches, particularly in light of existing literature.
by S. Müller, A. Hendricks, K. Uttinger, M. Kostatin, M. Brüggemann, M. Schrader, B. Polat, S. Flemming, J. F. Lock, C.-T. Germer, A. Wiegering, U. Pession
